Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Poop pills could tame gut disease

NCT ID NCT07154784

First seen Sep 30, 2025 · Last updated Jun 19, 2026 · Updated 28 times

Summary

This study tests whether transplanting healthy donor stool into the colon can help people with ulcerative colitis achieve long-term symptom control without steroids. Thirty participants aged 10 to 80 will receive the transplant via colonoscopy or capsules. The goal is to see if this approach can reduce inflammation and keep the disease in remission for up to 48 weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul National University College of Medicine

    Seoul, Dongjak-gu, 07061, South Korea

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

fecal microbiota transplantation (FMT)

What this could lead to

If it works, this could offer a new way to manage ulcerative colitis without long-term steroids, potentially reducing symptoms and improving quality of life.

What could go wrong

This is a small, early-phase trial with only 30 participants, so results may not apply to everyone. FMT is generally safe but can cause temporary digestive discomfort or, rarely, infection.

Conditions

The condition(s) this trial relates to.

ulcerative colitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.